• Baicalin methyl ester: Assay Design Guide

  2026-09-22

  A scenario-based guide to using Baicalin methyl ester (SKU N2884) in cell viability, proliferation, and LPS-induced intestinal barrier damage research. It covers concentration selection, solvent compatibility, controls, mechanistic readouts, and practical product-selection criteria supported by product data and literature.

• LAG-3–TCR Proximity in T Cell Suppression

  2026-09-22

  A 2025 Cell study shows that LAG-3-mediated inhibition depends not only on MHC class II binding but also on spatial proximity to the T cell receptor. By linking LAG-3 and the TCR with an Fc-attenuated bispecific antibody, the authors achieved broad T cell suppression and reduced autoimmune disease in mouse models, while identifying a CD3ε/Lck signaling mechanism.

• Mavorixafor in WHIM Syndrome: Phase 3 Evidence

  2026-09-21

  The reference commentary highlights a placebo-controlled phase 3 trial showing that oral CXCR4 inhibition with mavorixafor can extend neutrophil and lymphocyte availability and reduce infections in WHIM syndrome. Its main contribution is the translation of disease mechanism into a practical, sustained treatment strategy while also identifying unresolved questions about long-term safety, immune restoration, and cancer risk.

• 8-Chloroadenosine: Reliable RNA Assays

  2026-09-21

  A practical, scenario-driven guide to using 8-Chloroadenosine (SKU B7667) in RNA synthesis, viability, proliferation, and cytotoxicity workflows. It addresses stock preparation, dose–time design, interpretation of IL-6 and lncRNA experiments, and evidence-based product selection.

• 6C Medium Preserves Mouse Corneal Epithelial Growth

  2026-09-20

  An et al. developed a serum-free, feeder-free 6C culture system that combines six pathway modulators with keratinocyte calcium to prolong mouse corneal epithelial cell proliferative activity. By limiting epithelial-to-mesenchymal changes while retaining progenitor-associated markers, the approach improves generation of epithelial populations for wound-healing and regenerative-medicine studies.

• Phillygenin and Signaling in Diabetic Nephropathy

  2026-09-19

  The reference study identifies phillygenin as a potential intervention for diabetic nephropathy and links its protective effects to coordinated suppression of TLR4/MyD88/NF-κB inflammation and restoration of PI3K/AKT/GSK3β signaling. By combining high-glucose podocyte experiments, RNA sequencing, biochemical assays, and db/db mouse studies, it provides a preclinical framework for connecting reduced inflammation and apoptosis with improved renal function.

• Boc-D-FMK Workflows for Apoptosis Research

  2026-09-18

  Boc-D-FMK is a cell-permeable pan-caspase inhibitor for separating caspase-dependent apoptosis from upstream inflammatory signaling. This practical guide combines product-supported treatment conditions with renal, hepatic, and fibrosis-oriented assay strategies, while clearly distinguishing validated use from hypothesis-generating applications.

• Gallein and the Next Frontier of GPCR Translation

  2026-09-18

  Gallein offers translational researchers a way to interrogate G protein βγ-dependent signaling across cancer, immunity, cardiac inflammation, and emerging metabolic biology. By connecting validated preclinical applications with the lactate–GPR81/FARP1–RAC1 axis, this article outlines a rigorous strategy for testing whether Gβγ signaling contributes to insulin-independent glucose uptake without overstating current evidence.

• Protease Inhibitor Cocktail: EDTA-Free Workflow

  2026-09-17

  Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) helps limit endogenous proteolysis during protein extraction and sample preparation for Western blotting, co-immunoprecipitation, pull-downs, and phosphorylation-sensitive assays. It should not be treated as a complete phosphatase inhibitor system or used without compatibility testing in DMSO-sensitive assays and workflows that intentionally measure protease activity.

• HyperScript™ RT SuperMix for qPCR: Assay Logic

  2026-09-17

  HyperScript™ RT SuperMix for qPCR supports reproducible cDNA synthesis for complex or scarce RNA. This article uses a pedalitin–NAFLD study to show how reverse-transcription design influences gene expression interpretation and assay confidence.

• (R)-MG132: A Better Control for Metabolic Mechanisms

  2026-09-16

  A rigorous guide to using (R)-MG132, the functionally inactive MG-132 enantiomer, to separate proteasome-dependent effects from off-target stress in cancer metabolism and mechanistic studies.

• Dual-Action p38α Inhibition and Dephosphorylation

  2026-09-16

  The reference preprint shows that selected kinase inhibitors can do more than suppress p38α catalytic activity: they can also expose the activation-loop phosphothreonine to the phosphatase WIP1 and accelerate dephosphorylation. Its structural and biochemical framework provides a mechanistic basis for designing inhibitors that combine kinase blockade with phosphatase-facilitated pathway shutdown.

• Ceftolozane/Tazobactam: Evidence and Mechanism

  2026-09-15

  The reference review presents ceftolozane/tazobactam as an antipseudomonal cephalosporin and beta-lactamase inhibitor combination designed to address important resistance mechanisms in gram-negative infections. Its most useful contributions are the integration of PBP pharmacology, resistance biology, pharmacokinetics, pharmacodynamics, clinical evidence, and safety considerations into a framework for interpreting antibacterial research.

• Ambrosia Beetle Nests and Fungal Disease Spread

  2026-09-15

  A 2025 iScience study shows that spatial organization within Xyleborus affinis nests can limit the movement and consequences of Metarhizium infection, even though close contact increases disease risk. The work also identifies a Neocosmospora symbiont that inhibits Metarhizium growth, linking nest structure with microbial interactions as complementary forms of social immunity.

• Citron OGD2 and Iron-Dependent Canker Resistance

  2026-09-14

  The reference study identifies CmOGD2 as a central regulator of citron resistance to citrus canker, connecting iron uptake, reactive oxygen species accumulation, and probable ferroptosis-like cell death. It also reveals a CmOGD2–CmENO2–CmZAT10.1 feedback circuit that is disrupted by the Xanthomonas effector pthA4, providing a mechanistic framework for studying nutrient-dependent plant immunity.

7823 records 1/522 page Next 12345 下5页 Last page